About Index Trending news
Analyze
Top 50 Pricing
NovImmune

NovImmune

Work at NovImmune? Add yourself to this profile

NovImmune

NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.

Elsewhere

Alexa global traffic share

17 Dec 2010
$22,413,980
Venture capital (Series D)
BZ Bank
12 May 2009
$54,800,000
Venture capital (Series C)
01 Jun 2006
$46,000,000
Venture capital (Series B)
01 May 2000
$14,000,000
Venture capital (Series A)
Novartis Venture Fund, LODH Immunology Fund